Antibodies Asia 2012 – Expediting Development of Novel and Biosimilar Therapeutic Antibodies

Antibodies Asia 2012 – Expediting Development of Novel and Biosimilar Therapeutic Antibodies in Asia

20-23 February 2012 | Grand Hyatt Shanghai, China

 

Antibodies Asia Summit 2012 is the region’s premier conference on Antibodies Research & Development. Top scientists from pharma/biotech, universities and research institutes will convene in Shanghai to discuss the challenges, trends and collaboration opportunities in conducting Antibodies Research in Asia.

 

Find out the latest and upcoming trends in Antibodies research. Learn how Asia is faring vis a vis international research. Take advantage of this informative and thought-provoking meeting.

 

Examine future trends in antibodies development

Hear the latest strategies for protecting antibodies in our in-depth workshop

Learn from case studies on developments in recombinant antibodies as therapeutics

 

Co-located with:  Cell Line Development & Engineering Asia 2012 (Feb 21-23, SHANGHAI,CHINA)

 

Featuring presentations and case studies from leading experts:

 

ACADEMIA

Prof Roy Jefferis, Professor Emeritus: Molecular Immunology, School of Immunity & Infection, University of Birmingham, UK

Prof Koichi Kato, Professor, Okazaki Institute for Integrative Bioscience and Institute for Molecular Science, National Institutes

of Natural Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, Japan

Prof Yajun Guo, Director, Chinese National Engineering Research Centre for Antibody Medicine, China

 

INDUSTRY

Dr Jijie Gu, Principal Research Scientist,  Abbott Laboratories, USA

Prof Dr Dr Rolf Werner, Senior Vice President, Strategic  Biobusiness Asia, Boehringer Ingelheim, Germany

Dr Ton Logtenberg, Chief Executive Officer, Merus, The Netherlands

 

Plus

Dr. Andreas Seidl, Head Analytical Characterization, Site Head Oberhaching, Sandoz Biopharmaceuticals, USA

Prof Yong-Sung Kim, Associate Professor, Dept. of Molecular Science and Technology, Div. of Applied Chemistry & Biological Engineering,

Ajou University, Korea

Prof Dexian Zheng, Professor, National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical

Sciences & Peking Union Medical College, Qinghua University, China

Dr Larry Lo, Associate Director, Lead Development, Human Genome Sciences, USA

Dr Shun Luo, President, JS Biosciences, China

Dr Ralf Schumacher, Head of Biologics Research, Pharma Research and Early Development, Roche Diagnostics, Germany

 

Event highlights:

• Case studies from leading companies on revolutionizing therapeutic antibodies R&D

• Perspectives and future of antibody R&D from Abbott, Boehringer Ingelheim & Sandoz Biopharmaceuticals

• Innovation, trends and novel antibody development from Korea, Japan, China and Singapore

• Global perspective and updates from USA, UK, Germany, Netherlands and more…

 

Key themes and issues to be discussed include:

• Examining the Business and Regulatory Landscape

• Cell Line and Antibodies Development for Biosimilars

• Novel Antibody Target Discovery

• Revolutionizing Therapeutic Antibody R&D

• Insights on Antibody Engineering Using New Technology Platforms

• The Future of Therapeutic Antibodies in Asia

 

Who should attend?

 

By Job Titles

Chief Executive Officers, Chief Scientific Officers,

Vice Presidents, Professors, Heads, Directors,

 

Principal/Senior Scientists involved in:

• Antibody engineering, development and technology

• Recombinant DNA/molecular biotechnology

• Biotherapeutics

• Bio-analytical and Protein-analytical R&D, and analytical chemistry

• Preclinical/clinical research and development

• Biosimilars

• Business Development/ Licensing

 

From:

• Biopharmaceutical companies

• Biotechs

• CROs and CMOs

• Generics companies

• Venture Capitalists

• Universities and Research institutes

To find out more or to register your place, visit  http:///  or email register@ibcasia.com.sg

or call +65 6508 2401 (Singapore)/+86 21 2326 3680 (China).

 

I am looking forward to welcoming you at the Cell Line Development & Engineering Asia 2012.

 

Kind Regards

Elle Quan
Conference Producer